Ranbaxy Foils Mylan's Challenge To Valsartan Exclusivity
A Washington federal judge on Thursday tossed Mylan Pharmaceuticals Inc.'s suit against the U.S. Food and Drug Administration that attempted to gain marketing approval for its generic hypertension drug valsartan, saying...To view the full article, register now.
Already a subscriber? Click here to view full article